Global Acitretin Market, By Type (Branded, Generics), Application (Psoriasis, Solid Organ Transplants, Darier Disease, Pityriasis Rubra Pilaris (PRP), Ichthyoses, Grover Disease (Transient Acantholytic Dermatosis), Lichen Planus, Lupus Erythematosus), Dosage (10mg, 25 mg, 50mg), End-Users (Dermatology Clinics, Specialty Clinics, Hospitals, Ambulatory Surgical Centre, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Acitretin market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 3.90% in the above-mentioned research forecast period. Increase in prevalence of psoriasis and presence of pipeline drugs.
Moreover increasing demand of organ transplantation and enhanced increasing awareness towards psoriasis and its treatment options also boost up the market growth. Moreover, increasing research and development and rising healthcare expenditure act as opportunity for the market growth. But, sometimes adverse effect caused by acitretin, existence of alternative treatment options and its treatment options and disruption of supply chain due to impact of COVID 19 may hamper the global acitretin market.
Acitretin is a retinoid drug and has similar activity as that of the vitamin A. Acitretin is water soluble drug and is relatively less deposited in adipose tissue. Acitretin has been approved by FDA for psoriasis treatment involving pustular psoriasis generalized, pustular psoriasis localized, and severe plaque psoriasis among others. It can be used as either monotherapy or a combination therapy in conjunction with UVB (ultraviolet B), psoralen ultraviolet A (PUVA), with cyclosporine and also in combination with biological therapies. Acitretin is explored due to its anti- proliferative and anti- inflammatory effects. It works by suppressing the expression of proinflammatory cytokines such as interleukin-6 (IL-6). It is usually administer initially at a dosage of 25 to 50 mg for approximately 4 to 6 weeks and after that the dosage reduces to 10 mg or 25 mg.
According to per the report published by NCBI the incidence of psoriasis varies from 30.3 per 100,000 person each year in Taiwan, in Australia it’s up to 1.99%, in Latin America the estimate percentage is up to 2.96% along with increasing cases reported among other countries. The people suffering from psoriasis depend upon retinoid drugs and hence expected to provide market with the lucrative growth. It is also estimated that acitretin market is growing with the CAGR of 3.90% in 2020.
This acitretin market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Acitretin Market Scope and Market Size
Acitretin market is segmented on the basis of type, application, dosage strength, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the acitretin market is segmented into branded and generics.
- On the basis of application, the acitretin market is segmented into psoriasis, solid organ transplants, darier disease, pityriasis rubra pilaris (PRP), ichthyoses, Grover disease (transient acantholytic dermatosis), lichen planus, lupus erythematosus.
- On the basis of dosage strength, the acitretin market is segmented into 10mg, 25 mg and 50mg.
- On the basis of end-users, the acitretin market is segmented into dermatology clinics, specialty clinics, hospitals, ambulatory surgical centre and others.
- On the basis of distribution channel, the acitretin market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others.
Acitretin Market Country Level Analysis
Acitretin market is analysed and market size information is provided by country, anaesthesia type, application, dosage strength, end-users and distribution channel as referenced above.
The countries covered in the acitretin market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
North America accounts the largest market share due to the increasing adoption of inactive lifestyle and increasing product launch. Europe accounts the second largest market share due to enhanced distribution network and increasing cases of psoriasis that is 31.4 per 100 000 person years in Eastern Europe to 521.1 per 100 000 person years in Western Europe. Asia-Pacific is expected to account for the largest market share over coming years for the acitretin market due to increasing demand of effective treatment for skin diseases and presence of large number of acitretin manufacturers in China.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Acitretin market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Acitretin Market Share Analysis
Acitretin market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to acitretin market.
The major players covered in the acitretin market are Stiefel Laboratories, Inc., Teva Pharmaceuticals USA, Inc., Prasco Laboratories, Merck KGaA, Sun Pharmaceutical Industries Ltd, Hangzhou Jinlan Pharmaceutical Technology Development Co., Ltd., Chongqing Huapont Pharmaceutical Co., Ltd., AvKARE, LLC, Biophore, Olon S.p.A., GLOPEC INTERNATIONAL INC, Sionc Pharmaceuticals Pvt. Ltd., SGPharma Pvt. Ltd., Hepartex, Symbio Generrics (I) Pvt. Ltd., Highpharm Chem&Indu Co., Ltd., PAT IMPEX, Midas Pharma GmbH, among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available: Global Acitretin Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.